Table 5.
Summary of nanocomposites which are obtained by incorporating NPs into biopolymers developed through various AM techniques.
| Biopolymers | NPs | AM process | Applications | Ref. |
|---|---|---|---|---|
| Alginate | HAp | Bioprinting | Bone TE | [296] |
| PVA/sodium alginate/CNF | HAp | Extrusion | Bone TE | [297] |
| PLA/GelMA | Gold NPs | FDM | Bone TE | [298] |
| PCL | Mesoporous BGs | Bioprinting | Bone TE | [299] |
| PCL/PEG | β-TCP | Extrusion | Bone TE | [300] |
| PCL | HAp | SLS | Bone TE | [301] |
| PLLA/PHBV | CaP | SLS | Bone tissue regeneration | [302] |
| PCL | Zn/HAp/GO | Micro-extrusion | Bone TE | [303] |
| PCL/PEG | HAp | Extrusion | Bone tissue regeneration | [304] |
| GelMA | HAp | DLP | Bone TE | [305] |
| PCL/PLA | Halloysite | FDM | Bone tissue regeneration | [306] |
| PCL | Strontium/HAp | Extrusion | Bone TE | [307] |
| Alginate | BGs | Extrusion | Bone tissue regeneration | [308] |
| PCL | GO | Extrusion | Bone TE | [309] |
| PEGDA | CNCs | SLA | Soft TE | [310] |
| Alginate | MWCNTs | Extrusion | Vascular tissue regeneration | [311] |
| PCL | MWCNTs | Extrusion | Cardiac TE | [312] |
| PCL | CNFs | FDM | Drug eluting cardiovascular scaffolds | [313] |
| Chitosan/alginate | HAp | Hybrid 3D printing | Cartilage tissue regeneration | [314] |
| Alginate/thymoquinone | Halloysite | Extrusion | Cartilage tissue repairing | [315] |
| Xanthan gum | CNC | DIW | Liver TE | [316] |
| PLA | Halloysite | Extrusion | Soft TE | [317] |